Phase 2 study of oral thalidomide-cyclophosphamide-dexamethasone for recurrent/refractory adult Langerhans cell histiocytosis.
Leukemia
; 36(6): 1619-1624, 2022 06.
Article
in En
| MEDLINE
| ID: mdl-35361865
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Histiocytosis, Langerhans-Cell
/
Multiple Myeloma
Type of study:
Etiology_studies
Limits:
Adult
/
Humans
Language:
En
Journal:
Leukemia
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2022
Document type:
Article
Affiliation country: